Tuesday−Wednesday, January 14–15
10.00 CME/CE Credits
CME/CE Accredited Session
CME/CE Accredited Session
Non-CME Industry Theater
Treating MDD: A Rapid-Acting Oral Antidepressant With Multimodal Activity
Sponsored by Axsome Therapeutics, Inc.
CME/CE Accredited Session
CME/CE Accredited Session
Non-CME Industry Theater
Primary Care at the Forefront of Cardiovascular-Renal-Metabolic Diseases
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
CME/CE Accredited Session
CME/CE Accredited Session
CME/CE Accredited Session
Non-CME Industry Theater
VEOZAH™ (fezolinetant) For the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause
Sponsored by Astellas Pharma US, Inc.
CME/CE Accredited Session
Beyond SSRIs: Treating Complicated Depression
CME/CE Accredited Session
Non-CME Industry Theater
The Power of a First-in-Class Acid Suppressant: A Novel Treatment Option for Adults with GERD or H. Pylori Infection
Sponsored by Phathom Pharmaceuticals
CME/CE Accredited Session
CME/CE Accredited Session
Non-CME Industry Theater
Clinical Trial Data and Real-World Evidence Behind an Oral Treatment Option for Adult Patients at High Risk for Progression to Severe COVID-19
Sponsored by Pfizer, Inc.
Non-CME Industry Theater
Make the Time to Screen for Autoimmune Type 1 Diabetes (T1D)
Sponsored by Sanofi
CME/CE Accredited Session
Evaluation of Suspected Rheumatologic Conditions
CME/CE Accredited Session
CME/CE Accredited Session
Non-CME Industry Theater
Early Diagnosis of Alpha-1 Antitrypsin Deficiency To Help Patient Outcomes
Sponsored by Takeda Pharmaceuticals U.S.A., Inc.